Mercado global de herpes, por tipo de vírus (Herpes Simplex e Herpes Zoster), produto (aciclovir, docosanol, valaciclovir, famciclovir e outros), tipo de medicamento (medicamento sujeito a receita médica e medicamento de venda livre), idade (adulto e pediátrico), via De Administração (Tópica, Oral e Parentérica), Canal de Distribuição (Farmácias Hospitais, Farmácias de Retalho, Drogarias, Farmácias Online e Outras), Utilizadores Finais (Clínicas Especializadas e Outros) – Tendências do Sector e Previsão para 2031.
Análise e tamanho do mercado do herpes
O mercado do herpes abrange medicamentos sujeitos e não sujeitos a receita médica que visam as infeções pelo vírus herpes simplex (HSV). Os medicamentos prescritos como o valaciclovir (Valtrex) são amplamente utilizados para controlar os surtos e suprimir a atividade viral. As opções de venda livre, como os cremes tópicos que contêm docosanol (Abreva), oferecem alívio sintomático. Este mercado aborda tanto os tratamentos agudos como a gestão a longo prazo das infeções por HSV, atendendo às diversas necessidades e preferências dos consumidores.
A Data Bridge Market Research analisa que o mercado global de herpes, que foi de 1,24 mil milhões de dólares em 2023, deverá atingir os 2,06 mil milhões de dólares até 2031, com um CAGR de 6,6% durante o período de previsão de 2024 a 2031. Além dos insights sobre o mercado cenários como o valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de pacientes, análise pipeline, análise de preços e estrutura regulatória.
Âmbito e segmentação do mercado do herpes
|
Métrica de relatório |
Detalhes |
|
Período de previsão |
2024 a 2031 |
|
Ano base |
2023 |
|
Anos históricos |
2022 (personalizável para 2016-2021) |
|
Unidades Quantitativas |
Receita em biliões de dólares, volumes em unidades, preços em dólares |
|
Segmentos cobertos |
Tipo de vírus (Herpes Simplex e Herpes Zoster), Produto (Aciclovir, Docosanol, Valaciclovir, Famciclovir e outros), Tipo de medicamento (Medicamento sujeito a receita médica e Medicamento de venda livre), Idade (adulto e pediátrico), Via de administração (tópico, Oral e Parentérica), Canal de Distribuição (Farmácias Hospitais, Farmácias de Retalho, Drogarias, Farmácias Online e Outras), Utentes Finais (Hospitais, Clínicas Especializadas e Outros) |
|
Países abrangidos |
EUA, Canadá e México na América do Norte, Alemanha, França, Reino Unido, Holanda, Suíça, Bélgica, Rússia, Itália, Espanha, Turquia, Resto da Europa na Europa, China, Japão, Índia, Coreia do Sul, Singapura, Malásia , Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia-Pacífico (APAC), Arábia Saudita, Emirados Árabes Unidos, África do Sul, Egito, Israel, Resto do Médio Oriente e África (MEA) como parte do Médio Oriente e África (MEA), Brasil, Argentina e Resto da América do Sul como parte da América do Sul |
|
Participantes do mercado abrangidos |
Abbott (U.S.), Apotex, Inc. (Canada), Avet Pharmaceuticals, Inc. (U.S.), Bausch Health Companies, Inc. (Canada), Cipla, Inc. (India), Dr. Reddy’s Laboratories Ltd. (India), Fresenius Kabi AG (Germany), GSK plc (U.K.), GLENMARK PHARMACEUTICALS LTD (India), Maruho Co.,Ltd. (Japan), Mylan N.V. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Pharmaceuticals, Inc. (India), Recordati Industria Chimica e Farmaceutica S.p.A. (Italy), Aurobindo Pharma (India), Amneal Pharmaceuticals LLC (U.S.), Slavia Pharm S.R.L. (Romania), Blistex, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Herpes is a viral infection caused by herpes simplex virus (HSV), characterized by recurrent outbreaks of painful blisters or sores. HSV-1 primarily affects the mouth and face, while HSV-2 typically targets the genital area. It spreads through direct contact with infected individuals, and symptoms may include itching, tingling, and burning sensations.
Global Herpes Market Dynamics
Drivers
- Increasing Awareness about Prevention and Treatment
Efforts in public health campaigns, educational initiatives, and advocacy programs have heightened understanding about herpes transmission, symptoms, and available treatments. As awareness grows, individuals are more inclined to seek preventive measures and treatment options, contributing to market expansion. Ultimately, this heightened awareness serves as a significant driver propelling the herpes market forward.
- Improved Diagnostic Technologies Enhancing Early Detection
Advanced testing methods such as PCR assays and serological tests enable quicker and more accurate identification of herpes infections. Early detection facilitates prompt initiation of treatment, reducing transmission rates and severity of symptoms. Consequently, the demand for these diagnostic tools surges, serving as a pivotal driver propelling growth within the herpes market.
Opportunities
- Personalized Medicine Approaches for Improved Efficacy
Personalized medicine in the herpes market tailors treatment to individual patients based on genetic, environmental, and lifestyle factors. This approach allows for precise identification of the most effective therapies for each patient, potentially reducing side effects and improving outcomes. With advancements in genetic testing and data analytics, personalized medicine presents an opportunity to optimize treatment strategies and better manage herpes infections, meeting the diverse needs of patients while enhancing overall efficacy.
- Telemedicine Platforms Expanding Access to Care
Telemedicine platforms offer convenient access to herpes care, enabling remote consultations, prescriptions, and follow-ups. This approach eliminates geographical barriers, especially in underserved areas, and enhances patient engagement. With the rise of virtual healthcare, individuals can seek timely treatment and advice without the need for in-person visits. In the herpes market, leveraging telemedicine platforms presents an opportunity to improve accessibility, increase patient satisfaction, and ultimately optimize disease management.
Restraints/Challenges
- Regulatory Hurdles Delay Approval of New Treatments
The regulatory hurdles delays prolong the introduction of innovative therapies, limiting the market's ability to offer advanced solutions. Consequently, patients may face continued reliance on existing treatments, potentially hindering their efficacy and overall satisfaction. Moreover, the slower pace of introducing new products could stifle competition and innovation within the market, impacting its overall growth potential and the ability to address evolving patient needs.
- High Cost of Prescription Medications Hinders Access
The high cost of prescription medications limits the affordability of necessary treatments, potentially leading to financial strain or the inability to obtain medication altogether. As a result, individuals may forego or delay treatment, leading to prolonged suffering and increased transmission risks. Moreover, the financial burden on patients could discourage them from seeking proper medical care, impacting the market's overall revenue and growth potential.
This global herpes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global herpes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In October 2022, Replay, a genome writing company, introduced Eudora, a gene therapy firm focused on treating genetic retinal diseases using synHSV, a high payload capacity HSV delivery vector. This marks the debut of Replay's product companies utilizing synHSV, signaling a significant advancement in HSV-based gene therapy within the herpes market
- In August 2022, Rational Vaccines began a clinical trial in the U.K. to evaluate baseline characteristics of patients with recurrent symptomatic HSV type 2, informing protocol design for their lead HSV-2 therapeutic vaccine candidate. This underscores Rational Vaccines' commitment to advancing herpes treatment and prevention, aiming to revolutionize disease management within the herpes market
Global Herpes Market Scope
The global herpes market is segmented on the basis of virus type, product, drug type, age, route of administration, distribution channel, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Virus Type
- Herpes Simplex
- Herpes Zoster
Product
- Acyclovir
- Docosanol
- Valacyclovir
- Famciclovir
- Others
Drug Type
- Prescription Drug
- Over-the-counter Drug
Age
- Adult
- Pediatrics
Route of Administration
- Topical
- Oral
- Parenteral
Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- Others
End Users
- Hospitals
- Speciality Clinics
- Others
Global Herpes Market Regional Analysis/Insights
The global herpes market is analysed and market size insights and trends are provided by virus type, product, drug type, age, route of administration, distribution channel, and end users as referenced above.
The countries covered in the global herpes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to lead the global herpes market, driven by a rising prevalence of herpes infections in the region. The U.S., in particular, dominates this market, spearheading growth due to escalating herpes cases. This underscores the region's pivotal role in shaping the trajectory of the herpes market on a global scale.
The Asia-Pacific region anticipates significant growth in the herpes market from 2024 to 2031, attributed to an increasing geriatric population in countries such as China, Japan, and India. China leads this growth, fueled by rising disposable income levels. This underscores a growing market opportunity driven by demographic shifts and economic factors in the region.
A Europa espera um crescimento substancial no mercado do herpes de 2024 a 2031, impulsionado pelos avanços tecnológicos na região. A Alemanha domina na Europa, beneficiando de uma presença robusta de intervenientes no mercado. Isto realça o papel fundamental da tecnologia e do panorama competitivo na definição da trajetória do mercado do herpes na Europa.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias
O mercado global de herpes também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado global de herpes, impacto da tecnologia utilizando curvas de linha de vida e alterações nos cenários regulamentares de saúde e o seu impacto no mercado global de herpes. Os dados estão disponíveis para o período histórico 2016-2021.
Cenário competitivo e análise global da quota de mercado do herpes
O panorama competitivo do mercado global de herpes fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado global de herpes.
Alguns dos principais players que operam no mercado global do herpes são:
- Abbott (EUA)
- (Canadá)
- Avet Pharmaceuticals, Inc.
- Bausch Health Companies, Inc.
- Cipla, Inc. (Índia)
- (Índia)
- Fresenius Kabi AG (Alemanha)
- GSK plc (Reino Unido)
- GLENMARK PHARMACEUTICALS LTD (Índia)
- Maruho Co., Ltd. (Japão)
- Mylan NV (EUA)
- (EUA)
- Sun Pharmaceutical Industries Ltd. (Índia)
- (Israel)
- (Índia)
- Recordati Industria Chimica e Farmaceutica SpA (Itália)
- Aurobindo Pharma (Índia)
- Amneal Pharmaceuticals LLC (EUA)
- Slavia Pharm SRL (Roménia)
- (EUA)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL HERPES MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- Virus type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- market application coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- Summary write up (North America)
- OVERVIEW
- Summary write up (Europe)
- OVERVIEW
- Summary write up (Asia-Pacific)
- OVERVIEW
- Summary write up (South America)
- OVERVIEW
- Summary write up (Middle East and Africa)
- OVERVIEW
- global HERPES market: regulations
- THE U.S. REGULATORY FRAMEWORK
- CANADA REGULATORY FRAMEWORK
- THE EUROPE REGULATORY FRAMEWORK
- INDIA REGULATORY FRAMEWORK
- market overview
- drivers
- INCREASING geriatric population
- INCREASE IN prevalence of HERPES infections
- INCREASE IN NUMBER OF PRODUCT APPROVALS AND LAUNCHES
- RISING NUMBER OF Immunocompromised PEOPLE
- Restraints
- High cost of Anti-Herpetic medicines
- product recall
- opportunities
- strategic initiatives by the market players
- increasing healthcare expenditure
- SOARING NUMBER OF anti-herpetic drugs MANUFACTURERS
- RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
- challenges
- disruption in the supply chain of herpes drugs and injections during covid-19
- lack of workforce in pharma industries
- IMPACT OF COVID-19 ON GLOBAL HERPES MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS
- CONCLUSION
- GLOBAL HERPES MARKET, By VIRUS TYPE
- overview
- herpes simplex
- TYPE I
- TYPE II
- herpes zoster
- GLOBAL HERPES MARKET, By PRODUCT TYPE
- overview
- ACYCLOVIR
- Docosanol
- Valacyclovir
- Famciclovir
- others
- GLOBAL HERPES MARKET, By drug type
- overview
- Prescription Drug
- Over-The Counter Drug
- Global HERPES market, By age
- overview
- adult
- pediatrics
- Global herpes market, By ROUTE of administration
- overview
- topical
- oral
- Parenteral
- Global herpes market, By DISTRIBUTION CHANNEL
- overview
- hospitals pharmacies
- retail pharmacies
- Drug Stores
- Online Pharmacies
- others
- global herpes market, By end users
- overview
- hospitals
- Speciality Clinics
- Others
- GLOBAL herpes MARKET, BY REGION
- overview
- North AMERICA
- U.S.
- Canada
- Mexico
- europe
- Germany
- france
- U.K.
- Italy
- Spain
- russia
- turkey
- belgium
- netherlands
- switzerland
- luxemburg
- rest of europe
- Asia-pacific
- China
- India
- japan
- south korea
- australia
- Singapore
- thailand
- malaysia
- indonesia
- philippines
- rest of asia-pacific
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- REST OF SOUTH AMERICA
- middle east and africa
- south africa
- saudi arabia
- U.A.E.
- egypt
- israel
- rest of middle east and africa
- Global Herpes Market: COMPANY landscape
- company share analysis: Global
- company share analysis: North America
- company share analysis: Europe
- company share analysis: Asia-Pacific
- swot analysis
- company profile
- GLAXOSMITHKILNE PLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Viatris Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Fresenius Kabi AG
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- pfizer Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Amneal Pharmaceuticals LLC
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- apotex inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Avet Pharmaceuticals Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Bausch Health Companies Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- blistex, Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- cipla, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Dr. Reddy’s Laboratories Ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- EPIHEALTH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Glenmark Pharmaceutical Inc., USA (A Subsidiary of Glenmark Pharmaceuticals Ltd.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Maruho Co.,Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- RECORDATI S.p.A.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Slavia Pharm S.R.L.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Sun Pharmaceutical Industries Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Zydus Pharmaceuticals, Inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
Lista de Tabela
TABLE 1 The EMA has seven scientific committees that carry out its scientific assessments:
TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 3 MANUFACTURERS OF ANTI-HERPETIC DRUGS
TABLE 4 GLOBAL HERPES MARKET, By VIRUS Type, 2019-2028 (USD million)
TABLE 5 Global Herpes Simplex in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 6 Global Herpes Simplex in Herpes Market, By Virus Type, 2019-2028 (USD Million)
TABLE 7 Global Herpes Zoster in Herpes Market, BY Region, 2019-2028 (USD Million)
TABLE 8 Global Herpes Market, By Product Type, 2019-2028 (USD Million)
TABLE 9 Global Acyclovir in Herpes Market, BY Region, 2019-2028 (USD Million)
TABLE 10 Global Docosanol in Herpes Market, By Region, 2019-2028 (USD Million)
TABLE 11 Global Valacyclovir in Herpes Market, By region, 2019-2028 (USD Million)
TABLE 12 Global Famciclovir in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 13 Global Others in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 14 Global Herpes Market, By Drug Type, 2019-2028 (USD Million)
TABLE 15 Global prescription drug in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 16 Global Over-The Counter Drug in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 17 Global Herpes Market, By Age, 2019-2028 (USD Million)
TABLE 18 Global Adult in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 19 Global Pediatrics in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 20 Global Herpes Market, By Route of Administration, 2019-2028 (USD Million)
TABLE 21 Global Topical in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 22 Global Oral in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 23 Global Parenteral in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 24 Global Herpes Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 25 Global Hospitals Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 26 Global Retail Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 27 Global Drug Stores in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 28 Global Online Pharmacies in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 29 Global Others in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 30 Global Herpes Market, By End Users, 2019-2028 (USD Million)
TABLE 31 Global Hospitals in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 32 Global Speciality Clinics in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 33 Global Others in Herpes Market, by region, 2019-2028 (USD Million)
TABLE 34 GLOBAL herpes market, By region, 2019-2028 (usd THOUSAND)
TABLE 35 NORTH AMERICA HERPES market, By Country, 2019-2028 (USD Million)
TABLE 36 NORTH AMERICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 37 NORTH AMERICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 38 NORTH AMERICA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 39 NORTH AMERICA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 40 NORTH AMERICA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 41 NORTH AMERICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 42 NORTH AMERICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 43 NORTH AMERICA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 44 U.S. HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 45 U.S. herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 46 U.S. HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 47 U.S. HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 48 U.S. HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 49 U.S. HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 50 U.S. HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 51 U.S. HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 52 CANADA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 53 CANADA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 54 canada HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 55 CANADA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 56 CANADA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 57 CANADA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 58 CANADA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 59 CANADA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 60 MEXICO HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 61 MEXICO herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 62 MEXICO HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 63 MEXICO HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 64 MEXICO HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 65 MEXICO HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 66 MEXICO HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 67 MEXICO HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 68 EUROPE HERPES market, By Country, 2019-2028 (USD Million)
TABLE 69 EUROPE HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 70 EUROPE herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 71 EUROPE HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 72 EUROPE HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 73 EUROPE HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 74 EUROPE HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 75 EUROPE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 76 EUROPE HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 77 GERMANY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 78 GERMANY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 79 GERMANY HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 80 GERMANY HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 81 GERMANY HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 82 GERMANY HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 83 GERMANY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 84 GERMANY HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 85 france HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 86 france herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 87 FRANCE HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 88 FRANCE HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 89 FRANCE HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 90 FRANCE HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 91 FRANCE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 92 FRANCE HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 93 U.K. HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 94 U.K. herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 95 U.K. HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 96 U.K. HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 97 U.K. HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 98 U.K. HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 99 U.K. HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 100 U.K. HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 101 ITALY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 102 ITALY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 103 ITALY HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 104 ITALY HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 105 ITALY HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 106 ITALY HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 107 ITALY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 108 ITALY HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 109 SPAIN HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 110 SPAIN herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 111 SPAIN HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 112 SPAIN HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 113 SPAIN HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 114 SPAIN HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 115 SPAIN HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 116 SPAIN HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 117 RUSSIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 118 RUSSIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 119 RUSSIA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 120 RUSSIA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 121 RUSSIA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 122 RUSSIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 123 RUSSIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 124 RUSSIA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 125 TURKEY HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 126 TURKEY herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 127 TURKEY HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 128 TURKEY HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 129 TURKEY HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 130 TURKEY HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 131 TURKEY HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 132 TURKEY HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 133 BELGIUM HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 134 BELGIUM herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 135 BELGIUM HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 136 BELGIUM HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 137 BELGIUM HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 138 BELGIUM HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 139 BELGIUM HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 140 BELGIUM HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 141 netherlands HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 142 NETHERLANDS herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 143 NETHERLANDS HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 144 NETHERLANDS HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 145 NETHERLANDS HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 146 NETHERLANDS HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 147 NETHERLANDS HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 148 NETHERLANDS HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 149 SWITZERLAND HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 150 SWITZERLAND herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 151 SWITZERLAND HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 152 SWITZERLAND HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 153 SWITZERLAND HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 154 SWITZERLAND HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 155 SWITZERLAND HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 156 SWITZERLAND HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 157 LUXEMBURG HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 158 LUXEMBURG herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 159 LUXEMBURG HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 160 LUXEMBURG HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 161 LUXEMBURG HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 162 LUXEMBURG HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 163 LUXEMBURG HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 164 LUXEMBURG HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 165 rest of europe HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 166 ASIA-PACIFIC HERPES market, By Country, 2019-2028 (USD Million)
TABLE 167 ASIA-PACIFIC HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 168 ASIA-PACIFIC herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 169 ASIA-PACIFIC HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 170 ASIA-PACIFIC HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 171 ASIA-PACIFIC HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 172 ASIA-PACIFIC HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 173 ASIA-PACIFIC HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 174 ASIA-PACIFIC HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 175 CHINA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 176 CHINA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 177 CHINA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 178 CHINA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 179 CHINA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 180 CHINA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 181 CHINA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 182 CHINA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 183 india HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 184 india herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 185 india HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 186 india HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 187 INDIA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 188 INDIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 189 INDIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 190 INDIA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 191 JAPAN HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 192 JAPAN herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 193 JAPAN HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 194 JAPAN HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 195 JAPAN HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 196 JAPAN HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 197 JAPAN HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 198 JAPAN HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 199 SOUTH KOREA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 200 SOUTH KOREA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 201 SOUTH KOREA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 202 SOUTH KOREA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 203 SOUTH KOREA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 204 SOUTH KOREA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 205 SOUTH KOREA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 206 SOUTH KOREA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 207 AUSTRALIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 208 AUSTRALIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 209 AUSTRALIA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 210 AUSTRALIA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 211 AUSTRALIA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 212 AUSTRALIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 213 AUSTRALIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 214 AUSTRALIA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 215 SINGAPORE HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 216 SINGAPORE herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 217 SINGAPORE HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 218 SINGAPORE HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 219 SINGAPORE HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 220 SINGAPORE HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 221 SINGAPORE HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 222 SINGAPORE HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 223 THAILAND HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 224 THAILAND herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 225 THAILAND HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 226 THAILAND HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 227 THAILAND HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 228 THAILAND HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 229 THAILAND HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 230 THAILAND HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 231 malaysia HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 232 MALAYSIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 233 MALAYSIA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 234 MALAYSIA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 235 MALAYSIA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 236 MALAYSIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 237 MALAYSIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 238 MALAYSIA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 239 INDONESIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 240 INDONESIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 241 INDONESIA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 242 INDONESIA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 243 INDONESIA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 244 INDONESIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 245 INDONESIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 246 INDONESIA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 247 PHILIPPINEs HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 248 PHILIPPINEs herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 249 PHILIPPINEs HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 250 PHILIPPINES HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 251 PHILIPPINES HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 252 PHILIPPINES HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 253 PHILIPPINES HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 254 PHILIPPINES HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 255 rest of ASIA-pacific HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 256 SOUTH AMERICA HERPES market, By Country, 2019-2028 (USD Million)
TABLE 257 SOUTH AMERICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 258 SOUTH AMERICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 259 SOUTH AMERICA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 260 SOUTH AMERICA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 261 SOUTH AMERICA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 262 SOUTH AMERICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 263 SOUTH AMERICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 264 SOUTH AMERICA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 265 BRAZIL HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 266 BRAZIL herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 267 BRAZIL HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 268 BRAZIL HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 269 BRAZIL HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 270 BRAZIL HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 271 BRAZIL HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 272 BRAZIL HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 273 ARGENTINA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 274 ARGENTINA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 275 ARGENTINA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 276 ARGENTINA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 277 ARGENTINA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 278 ARGENTINA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 279 ARGENTINA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 280 ARGENTINA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 281 Rest of south america HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 282 MIDDLE EAST AND AFRICA HERPES market, By Country, 2019-2028 (USD Million)
TABLE 283 MIDDLE EAST AND AFRICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 284 MIDDLE EAST AND AFRICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 285 MIDDLE EAST AND AFRICA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 286 MIDDLE EAST AND AFRICA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 287 MIDDLE EAST AND AFRICA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 288 MIDDLE EAST AND AFRICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 289 MIDDLE EAST AND AFRICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 290 MIDDLE EAST AND AFRICA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 291 SOUTH AFRICA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 292 SOUTH AFRICA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 293 SOUTH AFRICA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 294 SOUTH AFRICA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 295 SOUTH AFRICA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 296 SOUTH AFRICA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 297 SOUTH AFRICA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 298 SOUTH AFRICA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 299 SAUDI ARABIA HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 300 SAUDI ARABIA herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 301 SAUDI ARABIA HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 302 SAUDI ARABIA HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 303 SAUDI ARABIA HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 304 SAUDI ARABIA HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 305 SAUDI ARABIA HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 306 SAUDI ARABIA HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 307 U.A.E. HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 308 U.A.E. herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 309 U.A.E. HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 310 U.A.E. HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 311 U.A.E. HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 312 U.A.E. HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 313 U.A.E. HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 314 U.A.E. HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 315 EGYPT HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 316 EGYPT herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 317 EGYPT HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 318 EGYPT HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 319 EGYPT HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 320 EGYPT HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 321 EGYPT HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 322 EGYPT HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 323 ISRAEL HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
TABLE 324 ISRAEL herpes simplex in HERPES MARKET, By virus Type, 2019-2028 (USD Million)
TABLE 325 ISRAEL HERPES MARKET, By product type, 2019-2028 (USD Million)
TABLE 326 ISRAEL HERPES MARKET, By drug type, 2019-2028 (USD Million)
TABLE 327 ISRAEL HERPES MARKET, By Age, 2019-2028 (USD Million)
TABLE 328 ISRAEL HERPES MARKET, By route of administration, 2019-2028 (USD Million)
TABLE 329 ISRAEL HERPES MARKET, By Distribution Channel, 2019-2028 (USD Million)
TABLE 330 ISRAEL HERPES MARKET, By End Users, 2019-2028 (USD Million)
TABLE 331 rest of middle east and africa HERPES MARKET, By virus TYPE, 2019-2028 (USD Million)
Lista de Figura
FIGURE 1 GLOBAL HERPES MARKET: segmentation
FIGURE 2 GLOBAL HERPES MARKET: data triangulation
FIGURE 3 GLOBAL HERPES MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL HERPES MARKET: global vs REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL HERPES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL HERPES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL HERPES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL HERPES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 GLOBAL HERPES MARKET: vendor share analysis
FIGURE 10 GLOBAL HERPES MARKET: SEGMENTATION
FIGURE 11 increasE IN prevalence of herpes infections and rise in healthcare expenditure are expected to drive THE GLOBAL HERPES MARKET IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 12 herpes simplex segment is expected to account for the largest share of the GLOBAL HERPES MARKET in 2021 & 2028
FIGURE 13 North America is expected to DOMINATE the GLOBAL HERPES MARKET, and ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 asia-pacific is the fastest-growing market for herpes market manufacturers in the forecast period of 2021 to 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF global Herpes market
FIGURE 16 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)
FIGURE 17 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)
FIGURE 18 GLOBAL HERPES MARKET : By VIRUS TYPE, 2020
FIGURE 19 GLOBAL HERPES MARKET : By VIRUS TYPE, 2019-2028 (USD million)
FIGURE 20 GLOBAL HERPES MARKET : By VIRUS TYPE, CAGR (2021-2028)
FIGURE 21 GLOBAL HERPES MARKET : By VIRUS TYPE, LIFELINE CURVE
FIGURE 22 GLOBAL HERPES MARKET : By PRODUCT TYPE, 2020
FIGURE 23 GLOBAL HERPES MARKET : By PRODUCT TYPE, 2019-2028 (USD million)
FIGURE 24 GLOBAL HERPES MARKET : By PRODUCT TYPE, CAGR (2021-2028)
FIGURE 25 GLOBAL HERPES MARKET : By PRODUCT TYPE, LIFELINE CURVE
FIGURE 26 GLOBAL HERPES MARKET : By DRUG TYPE, 2020
FIGURE 27 GLOBAL HERPES MARKET : By DRUG TYPE, 2019-2028 (USD million)
FIGURE 28 GLOBAL HERPES MARKET : By DRUG TYPE, CAGR (2021-2028)
FIGURE 29 GLOBAL HERPES MARKET : By DRUG TYPE, LIFELINE CURVE
FIGURE 30 GLOBAL HERPES MARKET: By AGE, 2020
FIGURE 31 GLOBAL HERPES MARKET: By AGE, 2019-2028 (USD million)
FIGURE 32 GLOBAL HERPES MARKET: By AGE, CAGR (2021-2028)
FIGURE 33 GLOBAL HERPES MARKET: By AGE, LIFELINE CURVE
FIGURE 34 Global herpes market: By route OF administration, 2020
FIGURE 35 Global HERPES market: By route OF ADMINISTRATION, 2019-2028 (USD million)
FIGURE 36 Global HERPES market: By route OF ADMINISTRATION, CAGR (2021-2028)
FIGURE 37 Global HERPES market: By route OF ADMINISTRATION, LIFELINE CURVE
FIGURE 38 Global herpes market: distribution channel, 2020
FIGURE 39 Global herpes market: DISTRIBUTION CHANNEL, 2019-2028 (USD million)
FIGURE 40 Global herpes market: DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 41 global herpes Global market: DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 Global herpes market: By end users, 2020
FIGURE 43 Global herpes market: Byend users, 2019-2028 (USD million)
FIGURE 44 Global herpes market: By end users, CAGR (2021-2028)
FIGURE 45 Global herpes market: By end users, LIFELINE CURVE
FIGURE 46 GLOBAL herpes market: SNAPSHOT (2020)
FIGURE 47 GLOBAL herpes market: by region (2020)
FIGURE 48 GLOBAL herpes market: by region (2021 & 2028)
FIGURE 49 GLOBAL herpes market: by region (2020 & 2028)
FIGURE 50 GLOBAL herpes market: by VIRUS TYPE (2021-2028)
FIGURE 51 NORTH AMERICA HERPES MARKET: SNAPSHOT (2020)
FIGURE 52 NORTH AMERICA HERPES MARKET: BY COUNTRY (2020)
FIGURE 53 NORTH AMERICA HERPES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 54 NORTH AMERICA HERPES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 55 NORTH AMERICA HERPES MARKET: BY virus TYPE (2021-2028)
FIGURE 56 EUROPE HERPES MARKET: SNAPSHOT (2020)
FIGURE 57 EUROPE HERPES MARKET: BY COUNTRY (2020)
FIGURE 58 EUROPE HERPES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 59 EUROPE HERPES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 60 EUROPE HERPES MARKET: BY virus TYPE (2021-2028)
FIGURE 61 ASIA-PACIFIC HERPES MARKET: SNAPSHOT (2020)
FIGURE 62 ASIA-PACIFIC HERPES MARKET: BY COUNTRY (2020)
FIGURE 63 ASIA-PACIFIC HERPES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 64 ASIA-PACIFIC HERPES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 65 ASIA-PACIFIC HERPES MARKET: BY virus TYPE (2021-2028)
FIGURE 66 SOUTH AMERICA HERPES market: SNAPSHOT (2020)
FIGURE 67 SOUTH AMERICA HERPES market: BY COUNTRY (2020)
FIGURE 68 SOUTH AMERICA HERPES market: BY COUNTRY (2021 & 2028)
FIGURE 69 SOUTH AMERICA HERPES market: BY COUNTRY (2020 & 2028)
FIGURE 70 SOUTH AMERICA HERPES market: BY virus TYPE (2021-2028)
FIGURE 71 MIDDLE EAST AND AFRICA HERPES MARKET: SNAPSHOT (2020)
FIGURE 72 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2020)
FIGURE 73 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 74 MIDDLE EAST AND AFRICA HERPES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 75 MIDDLE EAST AND AFRICA HERPES MARKEt: BY virus TYPE (2021-2028)
FIGURE 76 GLOBAL HERPES MARKET: COMPANY SHARE 2020 (%)
FIGURE 77 North America Herpes Market: company share 2020 (%)
FIGURE 78 Europe Herpes Market: company share 2020 (%)
FIGURE 79 Asia-Pacific Herpes Market: company share 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
